Showing 3061-3070 of 3158 results for "".
- The Medical Entrepreneur Symposium Adds New Session for Office Managershttps://practicaldermatology.com/news/20121017-the_medical_entrepreneur_symposium_adds_new_session_for_office_managers/2459702/The Medical Entrepreneur Symposium, a unique educational meeting for physicians, their office managers and executives in healthcare, has added an office manager focused breakout session called "Be A Better Office Manager." The symposium is based on the popularity of Dr. Steven Hacker's top-selling p
- ISHRS Kicks Off 20th Anniversaryhttps://practicaldermatology.com/news/20121003-ishrs_kicks_off_20th_anniversary/2459716/The International Society of Hair Restoration Surgery kicks off its 20th Anniversary this month. The ISHRS Annual Scientific Meeting is October 17-20 at Atlantis, Paradise Island, the Bahamas. The society is highlighting follicular units in hair res
- Jurlique Offers Holiday Discountshttps://practicaldermatology.com/news/20121002-jurlique_offers_holiday_discounts/2459718/Jurlique released holiday gift sets featuring full-sized product at a 30 to 40 percent savings. The products include: Age-Defying Trio, of Jurlique Purely Age-Defying Serum, Purely Age-Defying Ultra Firm and Lift Cream, and Skin Balancing Face Oi
- Janssen Launches Online Resource for Healthcare Professionalshttps://practicaldermatology.com/news/20121002-janssen_launches_online_resource_for_healthcare_professionals/2459725/Janssen Scientific Affairs recently launched a new online scientific resource for U.S. healthcare professionals seeking instant access to current information about Janssen products marketed in the U.S. JanssenMD (www.janssenmd.com) is a web-based application is designed for use on desktops, tablets,
- Physician Pessimism, Dissatisfaction Highhttps://practicaldermatology.com/news/20120928-physician_pessimism_dissatisfaction_high/2459726/More than half of American physicians participating in a recent survey say they plan to significantly modify their practice patterns over the next one to three years, new research suggests. They report plans to cut back on patients seen, work part-time, switch to concierge medicine, retire, or take
- Plastic Surgeons Use ExtendCredit to Provide Financing Services for Patientshttps://practicaldermatology.com/news/20120830-plastic_surgeons_use_extendcredit_to_provide_financing_services_for_patients/2459744/Riverside Plastic Surgery and San Diego-based SpiritLift Plastic Surgery recently started using ExtendCredit.com, an online software platform for creating and managing in-house customer financing plans for small to mid-sized businesses. The two practices now use ExtendCredit's fully automated, onlin
- Veil Cosmetics Introduced to Markethttps://practicaldermatology.com/news/20120727-veil_cosmetics_introduced_to_market/2459761/The concept of makeup artist Sébastien Tardif, Veil Cosmetics was inspired by Tardif's foundation in both art and fashion, which inspired the palette of bright-based colors that lift and illuminate the skin. Tardif cultivated his skincare sensibilities during his tenure in Asia, which led him
- Galderma's Cetaphil Celebrates 65 Yearshttps://practicaldermatology.com/news/20120711-galdermas_cetaphil_celebarates_65_years/2459775/Galderma's Cetaphil Gentle Skin Cleanser is celebrating 65 years on the market. Introduced in 1947 as Cetaphil Cleansing Lotion, it was initially developed by a pharmacist for use as a compounding base. By the 1960s, the product was so popular t
- Data Support Vismodegib for Metastatic, Locally Advanced BCChttps://practicaldermatology.com/news/20120613-data_support_vismodegib_for_metastatic_locally-advanced_bcc/2459783/New data demonstrate the anti-tumor activity of vismodegib (Erivedge, Genentech) 150mg daily in metastatic and locally advanced basal cell carcinoma (BCC). (N Engl J Med; 366:2171-2179) The study found that the independently assessed response rate was 30 percent in patients with metastatic BCC (n=33
- Stiefel, a GSK Company, Acquires Worldwide Rights to Toctino (alitretinoin)https://practicaldermatology.com/news/20120612-stiefel_a_gsk_company_acquires_worldwide_rights_to_toctino_alitretinoin/2459784/Stiefel, a GSK company, has entered into a worldwide agreement to acquire Toctino (alitretinoin) from Basilea Pharmaceutica Ltd. A once-daily oral retinoid, Toctino is in Phase 3 trials in the US, where it has not yet received FDA approval. Globally, it is the only prescription medicine specifically